This evidence supports the idea that cancer patients experiencing fatigue, anxiety, and depression may have elevated levels of circulating inflammation markers, such as interleukin‐6 (IL‐6) and C‐reactive protein (CRP) [115, 116, 117, 118]. This evidence concerns the gene IL6 and major depressive disorder.